Artificial intelligence (AI) is reshaping health care delivery, and pharmacy practice is no exception. AI is streamlining workflow, enhancing patient care, and challenging pharmacists to redefine their roles. Although AI holds great promise, it also raises questions about future job security and regulatory frameworks.
As a pharmacist working in both retail and hospital settings, I’ve witnessed firsthand the pressures mounting in our field, including higher patient loads, greater clinical responsibilities, and increasing administrative tasks. Amid this complexity, AI is emerging as a powerful tool, offering the potential to alleviate some of the burdens we face while also enhancing our ability to provide quality care.
In the hospital environment, AI-driven tools are already proving valuable. Clinical decision support systems flag drug interactions and dosing errors in real time. Algorithms aid in antimicrobial stewardship by analyzing resistance trends and recommending targeted therapies.1 In one hospital where I’ve practiced, AI models integrated into the electronic health record (EHR) predicted patient deterioration, prompting earlier interventions and improved outcomes.2 These systems are far from perfect, but they represent a shift toward proactive, data-driven pharmacy.
In the retail pharmacy, the opportunities are just as impactful. AI-based platforms are helping automate refill workflows, prior authorizations, and even patient communication. Predictive analytics can identify patients at risk of nonadherence or potential complications. AI tools can also support OTC recommendations based on symptoms and medication history, freeing up pharmacists to focus more on counseling and clinical services.1 I’ve personally seen how automation of insurance claim processing and smart inventory systems save hours of manual work every week.
Still, AI integration isn’t without challenges. One concern is data privacy, especially with cloud-based tools that interface with protected health information.3 There’s also the risk of bias in AI models, especially if they are trained on incomplete or non-representative data.4 Importantly, some pharmacists worry about losing their clinical intuition in favor of black-box suggestions that may not account for patient nuance. From my perspective, these concerns highlight the need for pharmacists to stay engaged in the development and testing of these tools.